Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bivona

Showing results (41-50 of 514) with videos related to

Pageof 52
Sort By:
Nature Medicine|May 6, 2016
A framework for understanding and targeting residual disease in oncogene-driven solid cancersTrever G Bivona, Robert C Doebele
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2012
Secrets of drug resistance in NSCLC exposed by new molecular definition of EMTDana S Neel, Trever G Bivona
NPJ Precision Oncology|November 21, 2017
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinomaDana S Neel, Trever G Bivona
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|June 20, 2018
Control measurements for lasers in physiotherapyRosanna Bivona, Alessandra Tomaselli, Francesco Frigerio
Therapeutics and Clinical Risk Management|August 30, 2008
Therapeutical approach to plasma homocysteine and cardiovascular risk reductionMarcello Ciaccio, Giulia Bivona, Chiara Bellia
Cancer Discovery|January 10, 2016
Tracking Down Response and Resistance to TRK InhibitorsRoss A Okimoto, Trever G Bivona
Personalized Medicine|December 16, 2014
Recent advances in personalized lung cancer medicineRoss A Okimoto, Trever G Bivona
Cancer Discovery|April 18, 2019
Engineering Multidimensional Evolutionary Forces to Combat CancerCaroline E McCoach, Trever G Bivona
Advances in Cancer Research|February 1, 2022
Inhibition of SHP2 as an approach to block RAS-driven cancersYu-Ting Chou, Trever G Bivona
International Journal of Molecular Sciences|July 27, 2024
Nucleic Acids-Based Biomarkers for Alzheimer's Disease Diagnosis and Novel Molecules to Treat the DiseaseGiulia Bivona, Selene Sammataro, Giulio Ghersi
Pageof 52

Showing results (41-50 of 514) with videos related to

Sort By:
Pageof 52
Nature Medicine|May 6, 2016
A framework for understanding and targeting residual disease in oncogene-driven solid cancersTrever G Bivona, Robert C Doebele
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2012
Secrets of drug resistance in NSCLC exposed by new molecular definition of EMTDana S Neel, Trever G Bivona
NPJ Precision Oncology|November 21, 2017
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinomaDana S Neel, Trever G Bivona
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|June 20, 2018
Control measurements for lasers in physiotherapyRosanna Bivona, Alessandra Tomaselli, Francesco Frigerio
Therapeutics and Clinical Risk Management|August 30, 2008
Therapeutical approach to plasma homocysteine and cardiovascular risk reductionMarcello Ciaccio, Giulia Bivona, Chiara Bellia
Cancer Discovery|January 10, 2016
Tracking Down Response and Resistance to TRK InhibitorsRoss A Okimoto, Trever G Bivona
Personalized Medicine|December 16, 2014
Recent advances in personalized lung cancer medicineRoss A Okimoto, Trever G Bivona
Cancer Discovery|April 18, 2019
Engineering Multidimensional Evolutionary Forces to Combat CancerCaroline E McCoach, Trever G Bivona
Advances in Cancer Research|February 1, 2022
Inhibition of SHP2 as an approach to block RAS-driven cancersYu-Ting Chou, Trever G Bivona
International Journal of Molecular Sciences|July 27, 2024
Nucleic Acids-Based Biomarkers for Alzheimer's Disease Diagnosis and Novel Molecules to Treat the DiseaseGiulia Bivona, Selene Sammataro, Giulio Ghersi
Pageof 52